Scientific Advisory Board
Han Seok Ko, Ph.D.
Professor of Neurology, Institute for Cell Engineering
Johns Hopkins University School of Medicine
Dr. Han Seok Ko is a Professor of Neurology and faculty member of the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. He is an internationally recognized neuroscientist focused on Parkinson's disease and related neurodegenerative disorders, with expertise in α-synuclein pathology, neuroinflammation, lysosomal dysfunction, and therapeutic target discovery. His research has contributed to key advances in Parkinson's disease pathogenesis and translational therapeutics.
Parkinson'sNeuroinflam.Alpha-SynucleinTargets
Scientific Advisory Board
Jae Gook Shin, M.D., Ph.D.
Professor, Pharmacology & Clinical Pharmacology, Inje University
Chief Executive Officer, SPMED Co., Ltd.
Dr. Jae Gook Shin is a leading clinical pharmacologist in Korea with extensive expertise in pharmacogenomics, personalized medicine, clinical PK/PD, drug metabolism, drug-drug interactions, clinical trials, and new drug development. He completed a clinical pharmacology fellowship at Georgetown University Medical Center and has held major leadership roles in clinical pharmacology, precision medicine, and clinical trial infrastructure. He has contributed to more than 350 SCI-level publications and over 35 patents.
Clinical Pharm.Pharmacogen.PK/PDClinical Trials
Scientific Advisory Board
Dong Hyun Kim, Ph.D.
Chief Technology Officer, SPMED Co., Ltd.
Professor Emeritus, College of Medicine, Inje University
Dr. Dong Hyun Kim is Chief Technology Officer at SPMED and Professor Emeritus at Inje University College of Medicine. He is an internationally recognized expert in ADME/DMPK, with extensive experience in drug metabolism, bioanalysis, pharmacokinetics, metabolomics, and drug-drug interaction assessment. His expertise supports IND/CTA-enabling programs, including DDI risk assessment, metabolite profiling, PK data interpretation, nonclinical-to-clinical translation, human dose projection, and dose justification.
ADME/DMPKMetabolismBioanalysisPK
Scientific Advisory Board
Eun Sun Choi, Pharm. / Patent Atty.
Chief Managing Partner, Choi & Partners
Patent Attorney / Pharmacist
Ms. Eun Sun Choi is Chief Managing Partner of Choi & Partners and a pharmacist and patent attorney with deep expertise in pharmaceutical and biotechnology intellectual property strategy. She has extensive experience in patent prosecution, IP portfolio strategy, patent litigation support, and freedom-to-operate counseling for life science and pharmaceutical technologies. Her background combines pharmacy training with advanced intellectual property law experience.
Pharma IPPatent Strat.FTOBiotech IP
